0001209191-21-026667.txt : 20210414 0001209191-21-026667.hdr.sgml : 20210414 20210414164446 ACCESSION NUMBER: 0001209191-21-026667 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210413 FILED AS OF DATE: 20210414 DATE AS OF CHANGE: 20210414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novo Holdings A/S CENTRAL INDEX KEY: 0001388325 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40315 FILM NUMBER: 21826153 BUSINESS ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 BUSINESS PHONE: 45 8824 8824 MAIL ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 FORMER NAME: FORMER CONFORMED NAME: Novo A/S DATE OF NAME CHANGE: 20070130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001637715 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472309515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 BUSINESS PHONE: 619-733-3852 MAIL ADDRESS: STREET 1: P.O. BOX 675614 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-13 0 0001637715 Reneo Pharmaceuticals, Inc. RPHM 0001388325 Novo Holdings A/S TUBORG HAVNEVEJ 19 HELLERUP G7 2900 DENMARK 0 0 1 0 COMMON STOCK 2021-04-13 4 C 0 2763711 A 2763711 D COMMON STOCK 2021-04-13 4 P 0 666666 15.00 A 3430377 D SERIES B CONVERTIBLE PREFERRED STOCK 2021-04-13 4 C 0 12367054 D COMMON STOCK 2763711 0 D Each share of Series B Convertible Preferred Stock converted into common stock at a ratio of 1:4.47848 into the number of shares of common stock as shown in Column 7 upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date. Represents a purchase from the underwriters in the Issuer's initial public offering. Novo Holdings A/S is a Danish limited liability company. The board of directors of Novo Holdings A/S (the "Novo Board") has shared investment and voting control over the securities of the Issuer held by Novo Holdings A/S (the "Shares") and may exercise such control only with the support of a majority of the Novo Board. As such, no individual member of the Novo Board is deemed to hold any beneficial ownership or reportable pecuniary interest in the Shares. /s/ Peter Haahr, Chief Financial Officer of Novo Holdings A/S 2021-04-14